Schmerztherapie bei Morbus Fabry

Translated title of the contribution: Pain therapy for Fabry's disease

C. Sommer, N. Üçeyler, T. Duning, K. Arning, R. Baron, E. Brand, S. Canaan-Kühl, M. Hilz, D. Naleschinski, C. Wanner, F. Weidemann

Research output: Contribution to journalArticlepeer-review

6 Scopus citations


Fabry's disease is an X-chromosome linked lysosomal storage disorder with α-galactosidase A deficiency and subsequent multiple organ involvement. An early and common symptom also in later stages of the disease is pain. This pain depends on various precipitating factors and can severely compromise the quality of life. So-called Fabry crises can lead to the necessity for intensive care treatment. The pain can be classified as predominantly neuropathic and is difficult to treat. In addition, medication has to be adjusted to concomitant cardiac and renal involvement in Fabry's disease. This review gives guidance for pain therapy in Fabry's disease based on the available evidence and on experience.

Translated title of the contributionPain therapy for Fabry's disease
Original languageGerman
Pages (from-to)121-130
Number of pages10
JournalDer Internist
Issue number1
StatePublished - Jan 2013
Externally publishedYes


  • Cardiomyopathies
  • Enzyme replacement therapy
  • Neuropathic pain
  • Phenytoin
  • Renal failure


Dive into the research topics of 'Pain therapy for Fabry's disease'. Together they form a unique fingerprint.

Cite this